214 related articles for article (PubMed ID: 24047962)
1. Production of anti-horse antibodies induced by IgG, F(ab')2 and Fab applied repeatedly to rabbits. Effect on antivenom pharmacokinetics.
Vázquez H; Olvera F; Alagón A; Sevcik C
Toxicon; 2013 Dec; 76():362-9. PubMed ID: 24047962
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics in rabbits and anti-sphingomyelinase D neutralizing power of Fab, F(ab')(2), IgG and IgG(T) fragments from hyper immune equine plasma.
Vázquez H; Olvera F; Paniagua-Solís J; Alagón A; Sevcik C
Int Immunopharmacol; 2010 Apr; 10(4):447-54. PubMed ID: 20093203
[TBL] [Abstract][Full Text] [Related]
3. Single-reagent one-step procedures for the purification of ovine IgG, F(ab')2 and Fab antivenoms by caprylic acid.
Al-Abdulla I; Casewell NR; Landon J
J Immunol Methods; 2014 Jan; 402(1-2):15-22. PubMed ID: 24246428
[TBL] [Abstract][Full Text] [Related]
4. Interspecies scaling of clearance and volume of distribution for horse antivenom F(ab')2.
Bazin-Redureau M; Pepin S; Hong G; Debray M; Scherrmann JM
Toxicol Appl Pharmacol; 1998 Jun; 150(2):295-300. PubMed ID: 9653060
[TBL] [Abstract][Full Text] [Related]
5. Snake antivenoms from hyperimmunized horses: comparison of the antivenom activity and biological properties of their whole IgG and F(ab')2 fragments.
Morais JF; de Freitas MC; Yamaguchi IK; dos Santos MC; da Silva WD
Toxicon; 1994 Jun; 32(6):725-34. PubMed ID: 7940578
[TBL] [Abstract][Full Text] [Related]
6. IgY pharmacokinetics in rabbits: implications for IgY use as antivenoms.
Díaz P; Malavé C; Zerpa N; Vázquez H; D'Suze G; Montero Y; Castillo C; Alagón A; Sevcik C
Toxicon; 2014 Nov; 90():124-33. PubMed ID: 25111201
[TBL] [Abstract][Full Text] [Related]
7. Snake F(ab')2 antivenom from hyperimmunized horse: pharmacokinetics following intravenous and intramuscular administrations in rabbits.
Pepin S; Lutsch C; Grandgeorge M; Scherrmann JM
Pharm Res; 1995 Oct; 12(10):1470-3. PubMed ID: 8584483
[TBL] [Abstract][Full Text] [Related]
8. Human heterophilic antibodies against equine immunoglobulins: assessment of their role in the early adverse reactions to antivenom administration.
León G; Segura A; Herrera M; Otero R; França FO; Barbaro KC; Cardoso JL; Wen FH; de Medeiros CR; Prado JC; Malaque CM; Lomonte B; Gutiérrez JM
Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1115-9. PubMed ID: 18561967
[TBL] [Abstract][Full Text] [Related]
9. Comparison between IgG and F(ab')(2) polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions.
León G; Monge M; Rojas E; Lomonte B; Gutiérrez JM
Toxicon; 2001 Jun; 39(6):793-801. PubMed ID: 11137538
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab')2-scorpion venom interactions.
Pépin-Covatta S; Lutsch C; Grandgeorge M; Lang J; Scherrmann JM
Toxicol Appl Pharmacol; 1996 Nov; 141(1):272-7. PubMed ID: 8917700
[TBL] [Abstract][Full Text] [Related]
11. Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations.
León G; Rodríguez MA; Rucavado A; Lomonte B; Gutiérrez JM
Biologicals; 2007 Mar; 35(1):5-11. PubMed ID: 16490363
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
Welfringer F; d'Athis P; Scherrmann JM; Hervé F
J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
[TBL] [Abstract][Full Text] [Related]
13. Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy.
Rivière G; Choumet V; Audebert F; Sabouraud A; Debray M; Scherrmann JM; Bon C
J Pharmacol Exp Ther; 1997 Apr; 281(1):1-8. PubMed ID: 9103473
[TBL] [Abstract][Full Text] [Related]
14. Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab')2 antivenoms.
Boyer LV; Chase PB; Degan JA; Figge G; Buelna-Romero A; Luchetti C; Alagón A
Toxicon; 2013 Nov; 74():101-8. PubMed ID: 23948058
[TBL] [Abstract][Full Text] [Related]
15. Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments.
Glennie MJ; McBride HM; Worth AT; Stevenson GT
J Immunol; 1987 Oct; 139(7):2367-75. PubMed ID: 2958547
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of 125I-labelled IgG, F(ab')2 and Fab fractions of scorpion and snake antivenins: merits and potential for therapeutic use.
Ismail M; Abd-Elsalam MA
Toxicon; 1998 Nov; 36(11):1523-8. PubMed ID: 9792168
[TBL] [Abstract][Full Text] [Related]
17. Modelling Tityus scorpion venom and antivenom pharmacokinetics. Evidence of active immunoglobulin G's F(ab')2 extrusion mechanism from blood to tissues.
Sevcik C; D'Suze G; Díaz P; Salazar V; Hidalgo C; Azpúrua H; Bracho N
Toxicon; 2004 Dec; 44(7):731-41. PubMed ID: 15500849
[TBL] [Abstract][Full Text] [Related]
18. Comparative study on the ability of IgG and F(ab')2 antivenoms to neutralize lethal and myotoxic effects induced by Micrurus nigrocinctus (coral snake) venom.
León G; Stiles B; Alape A; Rojas G; Gutiérrez JM
Am J Trop Med Hyg; 1999 Aug; 61(2):266-71. PubMed ID: 10463678
[TBL] [Abstract][Full Text] [Related]
19. High resolution fluorescence microscopy evidence on the transport of immunoglobulins. Differences between mammalian IgG, F(ab')2 and avian IgY.
Sevcik C; Salazar V; Díaz P; D'Suze G; Vázquez H
Toxicon; 2013 Mar; 63():7-18. PubMed ID: 23159396
[TBL] [Abstract][Full Text] [Related]
20. Mortality and antibody responses of mice to three successive episodes of experimental scorpion (Centruroides limpidus limpidus) envenomation and immunological rescue.
Padilla A; Govezensky T; Possani LD; Larralde C
Toxicon; 2005 Aug; 46(2):142-9. PubMed ID: 15946719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
